Cholinergic neurons use acetylcholine (ACh) as their primary neurotransmitter. These neurons play critical roles in motor control, learning, memory, attention, and autonomic functions.
Acetylcholine was the first neurotransmitter discovered, identified by Otto Loewi in 1921. Cholinergic neurons are distributed throughout both the central and peripheral nervous systems, where they subserve diverse functions ranging from voluntary motor control to cognitive processes.[1]
The cholinergic system consists of several key components:
Basal Forebrain Cholinergic System:
Brainstem Cholinergic System:
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000108 | cholinergic neuron |
The basal forebrain contains the largest population of cholinergic neurons in the brain. These neurons are organized into distinct nuclei that project to specific cortical and limbic regions:
Nucleus Basalis of Meynert (NBM): The primary source of cholinergic innervation to the neocortex. NBM neurons are particularly vulnerable in Alzheimer's disease, and their degeneration correlates with cognitive decline.[2][3]
Medial Septal Nucleus (MSN): Projects to the hippocampus and is essential for theta rhythm generation and spatial memory consolidation.[4]
Diagonal Band of Broca: Contains both horizontal and vertical limbs, projecting to the hippocampus and olfactory bulb.
Pedunculopontine Nucleus (PPN): Located in the pontine tegmentum, these cholinergic neurons are critical for REM sleep regulation and arousal. PPN degeneration contributes to sleep disturbances in Parkinson's disease.[5]
Laterodorsal Tegmental Nucleus (LDT): Modulates mesolimbic dopamine release and is involved in reward learning and addiction.[6]
Cholinergic neurons play crucial roles in basal ganglia function through several mechanisms:
The striatum contains cholinergic interneurons (also known as tonically active neurons or TANs) that modulate striatal output:[7]
Basal forebrain cholinergic projections to the basal ganglia:
Cholinergic degeneration is a hallmark of Alzheimer's disease:[2:1][3:1][8]
Cholinergic dysfunction contributes to PD symptoms:[5:1][9]
Nicotinic Receptors (nAChRs):
Muscarinic Receptors (mAChRs):
The cholinergic hypothesis of Alzheimer's disease posits that loss of cholinergic neurons in the basal forebrain contributes to the cognitive deficits observed in AD patients.[10] This hypothesis has driven therapeutic strategies for decades.
In Alzheimer's disease, cholinergic neurons in the nucleus basalis of Meynert undergo significant degeneration. Post-mortem studies reveal:
Current FDA-approved treatments for AD symptoms include:
Despite initial benefits, cholinesterase inhibitors provide:
Muscarinic Receptors (mAChRs)
Nicotinic Receptors (nAChRs)
Sarter M, Bruno JP. Cortical cholinergic projections: cognitively relevant cortical processing. 2004. ↩︎
Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. 1983. ↩︎ ↩︎
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. 1982. ↩︎ ↩︎
Blusztajn JK, Berse B. The cholinergic neuronal phenotype in Alzheimer's disease. 2000. ↩︎
Shin J, Lim J, Lee K, Choi J. Pedunculopontine nucleus degeneration in Parkinson's disease. 2021. ↩︎ ↩︎
Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. 1991. ↩︎
Pisani A, Bernardi G, Ding J, Surmeier DJ. Re-emergence of striatal cholinergic interneurons in movement disorders. 2007. ↩︎
Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. 1976. ↩︎
Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. 2011. ↩︎
Bartus RT. On neurodegenerative diseases, models, and treatment strategies. 1983. ↩︎
Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. 1983. ↩︎
Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. 1981. ↩︎
Wilcock GK, Esiri MM, Bowen DM, Smith CC. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. 1982. ↩︎
Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease. 1998. ↩︎
Birks JS, Harvey R. Rivastigmine for Alzheimer's disease. 2003. ↩︎
Olin J, Schneider L. Galantamine for Alzheimer's disease. 2002. ↩︎
Birks JS. Cholinesterase inhibitors for Alzheimer's disease. 2006. ↩︎
Fisher A. Muscarinic M1 agonists as novel potential treatments for Alzheimer's disease. 2008. ↩︎
Brady AE, Jones CK, Conn PJ. Allosteric modulation of metabotropic glutamate receptors. 2008. ↩︎
Mazurov AA, Speake SD, Yohannes D. Discovery and development of alpha7 neuronal nicotinic acetylcholine receptor (nAChR) agonists for the treatment of cognitive disorders. 2011. ↩︎
Wallace TL, Porter RH. Targeting the nicotinic alpha4beta2 receptors for CNS disorders. 2011. ↩︎
Tuszynski MH, Thal L, Pay M, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. 2005. ↩︎
Liu Y, Weick JP, Liu H, et al. Medial ganglionic eminence-derived neural stem cell grafts ease behavioral deficits and restore cholinergic circuitry in a mouse model of Alzheimer's disease. 2013. ↩︎
Nagahara AH, Tuszynski MH. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. 2011. ↩︎
Houser CR, Crawford GD, Barber RP, Salvaterra PM, Vaughn JE. Organization and morphological characteristics of cholinergic neurons. 1983. ↩︎
Lautenslager GT, Kellar KJ, Schofield GN. Choline acetyltransferase mRNA in rat brain. 1989. ↩︎
Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. 2005. ↩︎
Westerink BH, De Vries GE. Characterization of in vivo dopamine release in the striatum. 1988. ↩︎
Ungerstedt U. Intracerebral microdialysis--a new technique for studying drug action in the awake animal. 1991. ↩︎
Grienberger C, Konnerth A. Imaging calcium in neurons. 2012. ↩︎